Ligand validation:9HAQ

NLE: NORLEUCINE

NLE is a Ligand Of Interest in 9HAQ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9HAQ_NLE_B_401	68%	54%	0.097	0.907	1.08	0.7	-	-	2	0	100%	1
9HAQ_NLE_D_401	64%	60%	0.128	0.927	0.91	0.65	-	-	0	0	100%	1
9HAQ_NLE_F_401	37%	59%	0.143	0.839	0.86	0.71	-	-	3	0	100%	1
9HAQ_NLE_J_401	34%	58%	0.17	0.854	0.82	0.8	-	-	3	0	100%	1
9HAQ_NLE_A_401	32%	57%	0.175	0.847	0.81	0.85	-	-	3	0	100%	1
9GJ9_NLE_E_401	73%	54%	0.112	0.939	0.85	0.93	-	-	1	0	100%	1
1MMT_NLE_A_1427	73%	49%	0.135	0.961	1.25	0.75	1	-	0	0	100%	1
5JK8_NLE_B_504	71%	57%	0.108	0.928	0.78	0.89	-	-	0	0	100%	1
5M3Z_NLE_A_402	25%	23%	0.193	0.83	1.09	2.07	1	4	2	0	100%	0.7
3JWB_NLE_A_399	13%	33%	0.207	0.744	0.96	1.69	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.